News

Societal Impact of Pain Symposium 2014

Off

 

logo SIP (3) 

 

Preliminary Draft for

Societal Impact of Pain

 SIP Symposium 2014

Interactive Panel Discussions

 5th European Annual Event

  European Parliament

Brussels

60 rue Wiertz /
Wiertzstraat 60,

Room to be announced

 November 18th 2014

 

SIP Symposium 2014 – Interactive Panel Discussions

 

Pain therapy and palliative care will be listed as healthcare priorities during the Italian presidency of the EU council in the second semester of 2014.This is exciting because for the first time ever all EU Ministers of Health will be called upon to discuss how to direct national and European strategies and health policies to address the need for improved pain care in Europe.

 Considering the importance of this announcement it was also decided to celebrate the 5th SIP symposium by inviting Nick Ross, widely regarded as one of the most professional conference moderators in the world. The intention is to break away completely from the traditional format by invited leading European stakeholders to join a series of provocative and audience interactive panel discussions and interviews. The aim will be to define what needs to be done now to ensure that chronic pain and palliative care will receive the priority on the agenda of the EU institutions and the member states also in the long term.

 

  Aims of the SIP Platform

The European, multi-stakeholder platform Societal Impact of Pain (SIP) was created in 2010 as a joint initiative of the European Pain Federation EFIC® and the pharmaceutical company Grünenthal GmbH. The aims are to

  • raise awareness of the relevance of the impact that pain has on our societies, health and economic systems;
  • exchange information and share best-practices across all member states of the European Union;
  • develop and foster European-wide policy strategies & activities for an improved pain care in Europe.

As a multi-stakeholder platform SIP provides opportunities for discussion for health care professionals, pain advocacy groups, politicians, insurances, representatives of health authorities, regulators and budget holders. The scientific framework of the SIP platform thereby is under the responsibility of EFIC®. Grünenthal is responsible for funding and non-financial support (e.g. logistical support).

 

Endorsement of the SIP Platform

As in the past we anticipate endorsement of the event by the EU council and > 180 international organisations. Here the link to a list of our endorsers.

Registration

Deadline for registration is September 30th  –   2014  Please register your   participation via this link https://www.regonline.com/sip2014

Contact numbers

 EFIC Office: secretary@efic.org or +32 (2) 251 55 10

Preliminary programme

  Tuesday 18th of November

Simultaneous translation will be provided in Italian, Spanish, French, German, English

 

8:45 Meet at the Spinelli   entrance of the European Parliament, 60 rue Wiertz ( towards Place Luxembourg   ) to collect your entry badge.  

Please note all delegates will be accompanied to the meeting room in   the parliament and that in the registration process the following information   has to be provided in order to obtain the entry badges for the European   Parliament : date of birth, ID or passport number and nationality

 

9:30 Opening and Welcome
9:35 Panel Discussion 1 :  Out of sight, out of mind   – why the reluctance to see pain as a critical issue

 

Panelists:

-To be announced

 

Aims

  •   Confirming briefly the key facts relating to the impact of chronic   pain on European society from different perspectives.
  •   What are the consequences of ignoring Chronic Pain when defining the   European health policy agenda
  •   Elaborate a better understanding of why there is such a reluctance to   see Chronic Pain as a critical issue and why pain is still largely absent   from the policy agenda of the majority of member states and also the EU   institutions.
  •   As chronic pain treatment and palliative care is not optimally or   equitably achieved across Europe there is still a need to understand better   the barriers and to explore in more depth the solutions to overcome these   barriers. 
  •   Understand the major hurdles that will need to be addressed in order   to elevate the importance of pain therapy and palliative care on both the EU   and member state level
  •   Define concrete actions that will result in new momentum that will   lead to the changes desperately needed by patients in Europe.

 

10:30 -11:00 Refreshment break

 

11:00-12:00 Panel Discussion 2:  Good Practise –how do we   stimulate innovation and accelerate the replication

 

Panelists:

-To be announced

 

Aims

  •   Since 2010 some examples of good practice in pain care has been   presented several times and it is time to ask what needs to be done to   accelerate the replication of these examples of good practice.
  • Why if effective   treatments and strategies exist are these not being implemented effectively   or with equity across Europe
  • What are the real   hurdles that are preventing the widespread uptake of such best practice   examples considering the convincing evidence and what can be done to overcome   these hurdles
    •   Define clearly what needs to be done now to ensure that the 5 examples   of good practice in pain collected and studied by the B3 Action Group on   integrated care is considered for replication by the reference sites across   Europe and also what the SIP partners and endorsers need to do in order to   support the European Innovation Partnership on Active and Healthy Aging to   reach its ambitious goals.
    •   Explore what is needed to stimulate a fresh wave of innovation that   will inspire better outcomes for patients
12:00-13:00 Lunch – EU Parliament

 

13:00-14:00 Panel Discussion 3:  Declaration   of the Italian Presidency* on Pain and Palliative Care  What now

 

Panelists:

– To be announced

– Italian minister of Health to be confirmed

– Senior delegates from other ministries of health to be confirmed

 

Aims:

  • Provide a platform to the   Italian Presidency of the EU council for furthering their political objective   which is to ensure that pain and palliative care will receive a high priority   in the agenda of the member states and also the European institutions in the   future.
  • Define the role that the   SIP partners and endorsers can play to ensure the outcomes from the efforts   and the work of the Italian Presidency will be used to ensure new forward   momentum in the advocacy work for improved recognition for the need to   improve pain policy in Europe.
  • The content for this   panel discussion will be developed in very close cooperation with the Italian   Ministry of Health and the Ministry of European Affairs
  • Of interest in this panel   discussion would be also the example of the Spanish strategy for addressing   chronic diseases where one of the four pillars was defined as an Improvement   in the chronic pain approach.

 

*Confirmation from the   Italian Presidency that a declaration on pain therapy and palliative care   will follow the informal health council meeting on 22nd and 23rd of September   is awaited.

 

14:00-14:30 Refreshment break 

 

14:30- 15:30 Panel Discussion 4:  The   future – How can stakeholders advocating for the   recognition of pain in Europe work together to ensure change

Panelists:

-To be announced

 

Aims

 

  • Identify how each stakeholder group will define   success in 1-2 years time
  • What are the current hurdles to closer   cooperation that should be addressed and what are the opportunities for   closer cooperation of the relevant stakeholders
  •   Agreeing what the   different stakeholders will do to work together better in the future and to ensure   that pain remains visible on the EU and National Policy agenda
  •   Define what are the   priorities that each stakeholder group should address in their own camp to   ensure that patients can look forward to real progress and positive change in   pain therapy and palliative care
  • Define what needs to be   done urgently to bring new fresh momentum to the advocacy work on Chronic   Pain  
15:30  Closing remarks  :  Prof Chris Wells , President EFIC  
16:00 Departure

 

Faculty :

The experts below have already confirmed their participation as panellists. Confirmation about the participation of the EU institutions will take place after the start of the new term for elected and appointed officials

 

  • Chris Wells: President of the European Pain Federation EFIC®

 

  • Hans Kress: Immediate Past President of the European Pain Federation EFIC®

 

  • Bart Morlion: President-Elect of the European Pain Federation EFIC®

 

  • Giustino Varrassi: EU liaison officer and Past President of the European Pain Federation EFIC®

 

  • Minister of Health: Italy to be confirmed

 

  • Willem Scholten: Consultant – Medicines and Controlled Substances and formerly with the WHO Access to Controlled Medicines

 

  • Robert Johnstone: Board member of the International Alliance of Patients

 

  • Günter Danner: Deputy Director Liaison Bureau of the German Social Security institutions

 

  • Audrey Craven: President of the European Federation of Neurological Associations

 

  • Ceri Philips: Professor of Health Economics and Head of the Institute for Health Research

 

  • Rolf-Detlef Treede: President-Elect of the International Association for the Study of Pain

 

  • Neil Betteridge: Vice Chair of the Chronic Pain Policy Coalition

 

  • David Hughes, Professor of Health Economics, University of Chester

 

  • Das Meherzin: Consultant Clinical Psychologist and clinical lead of Dorset Community Pain Service

 

  • Ernst Daniel Smid: Founder of Stichting Pijn Bij Kanker

 

  • Invitation process ongoing

 

About SIP

The “Societal Impact of Pain” platform (SIP) is an international platform created in 2010 as a joint initiative of EFIC and the pharmaceutical Grünenthal GmbH and aims for 1) raising awareness of the relevance of the impact that pain has on our societies, health and economic systems 2) exchanging information and sharing best-practices across all member states of the European Union 3) developing and fostering European-wide policy strategies & activities for an improved
pain care in Europe (Pain Policy).The platform provides opportunities for discussion for health care professionals, pain advocacy groups, politicians, insurances, representatives of health authorities, regulators and budget holders.

 The scientific framework of SIP is under the responsibility of the European Pain Federation EFIC® . The pharmaceutical company Grünenthal GmbH is responsible for funding and non-financial support (e.g. logistical support).The scientific aims of the SIP symposia have been endorsed by a large number of international and national pain advocacy groups, scientific organisations and authorities.

More information: http://www.sip-platform.eu/

Background about past SIP events

In the past four years EFIC® and Grünenthal have organized four European scientific symposia on the societal impact of chronic pain in Europe: The first symposium SIP 2010 established the multi-stakeholder network and thus a platform for sharing best practices of pain management throughout Europe.

The second symposium SIP 2011 took place in the European Parliament and was supported by all three European institutions: Members of the EU Parliament, the EU Commissioner for Health & Consumer Policy, as well as the Hungarian Presidency holding the EU Presidency from Jan-Jun 2011. Furthermore, it was endorsed by more than 85 international and national patient advocacy groups, scientific organisations and health authorities. Key result from SIP 2011 was the SIP Road Map for Action outlining seven policy dimensions on how the EU institutions and member states can effectively address the societal impact of pain at EU level.

The third symposium SIP 2012 took place in Copenhagen, Denmark. More than 400 stakeholders from more than 30 countries participated in the meeting, which was officially held under the high patronage of the Italian Prime Minister and the Italian Ministry of Health and Welfare, and which was endorsed by more than 161 organisations. For the first time concrete national policies on pain management were shared with the participants reflecting how EU Member States succeeded to implement the SIP Road Map for Action on national level.

In 2013 the programme committee hosted the SIP Focus Groups in Brussels, endorsed by > 180 organisations. The focus groups concentrated on two concrete policy topics linked to the SIP Road Map for Action. The first focus group served as an initial face-to-face event for a group of European experts that aims to develop “Recommendations for a European set of quality indicators for chronic non-malignant pain management”. The project is ongoing and EFIC has appointed a dedicated taskforce to deal with this important topic. The second focus group hosted in the European Parliament served as an opportunity for sharing best practices and exchanging models among EU Member States for keeping our workforce healthy. A “Proposal for Action”, giving national examples of rehabilitation and integrated care programs and proposals for concrete measures on EU policy level was developed and several of the best practice examples presented are now formally included in the compilation of good practice examples published by the European Commission as part of the European Innovation Partnership on Active and Healthy Aging.  

 

About European Pain Federation EFIC®

The European Pain Federation EFIC® is a multidisciplinary professional organisation in the field of pain research and medicine, consisting of the 36 chapters of the International Association for the Study of Pain (IASP®), which are the IASP approved official National Pain Societies in each country. Established in 1993, EFIC’s constituent chapters represent Pain Societies from 36 European countries and close to 20,000 physicians, basic researchers, nurses, physiotherapists, psychologists and other healthcare professionals across Europe, who are involved in pain management and pain research.

More information: http://www.efic.org/

About Grünenthal

The Grünenthal Group is an independent, family-owned, international research-based pharmaceutical company headquartered in Aachen, Germany. Building on its unique position in pain treatment, its objective is to become the most patient-centric company in the field of pain and thus to be a leader in therapy innovation.

More information: http://www.grunenthal.com

USEFUL LINKS

Societal Impact of Pain  – website of the SIP platform with in-depth content and news

The European Pain Federation EFIC® – website with details on EFIC® activities and chapters

Nick Ross – conference moderator

Latest Euroscicon Tweets

  • After finishing our conference Fifth Edition of International Conference on #OccupationalHealth and Public Safety w… https://t.co/CJ5cefOTHs
    about 17 hours ago